Ignite Creation Date:
2024-05-06 @ 10:46 AM
Last Modification Date:
2024-10-26 @ 12:35 PM
Study NCT ID:
NCT03342040
Status:
COMPLETED
Last Update Posted:
2019-02-15
First Post:
2017-09-29
Brief Title:
Transverse Abdominis Plane Block in Laparoscopic Ventral Hernia Repair
Sponsor:
GEM Hospital Research Center
Organization:
GEM Hospital Research Center
Study Overview
Official Title:
Randomized Clinical Trial Transverse Abdominis Plane Block Versus no Block in Laparoscopic Ventral Hernia Repair
Status:
COMPLETED
Status Verified Date:
2019-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The current study aims to determine if transverse abdominis plane block using local anesthetic agents bupivacaine 025 Ropivacaine 020 decreases the post operative pain and helps in early mobilization or discharge from hospital in patients undergoing laparoscopic ventral hernia repair
Detailed Description:
Patients meeting inclusion criteria would be randomised after admission Those patients in experimental arm shall receive the TAP block under USG guidance while those in control arm do not receive any block Surgery shall be proceeded in the usual manner in all the patients and assessment for pain starts in the immediate post operative or recovery room after the patient is completely conscious The total amount of analgesic required by the patient is measured Pain assessment is done using the visual analog scale VAS at regular intervals until follow up review
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None